Tuberculosis. Beating the bacillus.
The identification of the target of isoniazid in the mycobacterial tuberculosis pathogen opens the way for the developoment of new drugs and diagnostic tests to combat drug-resistant pathogen strains.
Young
D B
DB
Department of Medical Microbiology, St Mary's Hospital Medical School, London, UK.
D000818:Animals; D004352:Drug Resistance, Microbial / Q000235:genetics; D005798:Genes, Bacterial; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology*; D008954:Models, Biological; D009154:Mutation; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics; D014376:Tuberculosis / Q000188:drug therapy
D007538:Isoniazid